Mayo Clinic

FL 32224 (Unknown)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£1,207,373

Jun 15 - May 17

First-in-class Selective IKKalpha Inhibitors for the Treatment of Castrate Resistant Prostate Cancer (CRPC) and Pancreatic Cancer

MRC award to University of Strathclyde and Simon Mackay

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}